Brief: Reshape Lifesciences Receives FDA 510(K) Clearance For The Gibi HD Calibration Tubes For Use In Gastric And Bariatric Procedures
Aug 10 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES™ RECEIVES FDA 510(K) CLEARANCE FOR
THE GIBI
HD™ CALIBRATION TUBES FOR USE IN GASTRIC AND BARIATRIC
PROCEDURES
* RESHAPE LIFESCIENCES INC - COMPANY TO INTRODUCE PRODUCT AT
IFSO
2022 WORLD CONGRESS IN AUGUST; SALES TO COMMENCE IN SEPTEMBER
* RESHAPE LIFESCIENCES INC - EXPECTS U.S. COMMERCIAL SALES
TO
BEGIN IN SEPTEMBER 2022
Source text for Eikon: urn:newsml:reuters.com:*:nGNX4WpvT1
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity